Physician profile
William J Leahy
NPI 1447245774
$19,589.01
in general payments reported to CMS, 2019-2025
73 companies · $3,088 in 2025
The $3,088 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,678 · 2020: $2,490 · 2021: $2,841 · 2022: $2,287 · 2023: $3,261 · 2024: $2,944 · 2025: $3,088.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,228 · Education: $64.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,228.41 |
| Education | $64.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,671.38 | 2021-2025 | |
| Novo Nordisk INC | $2,499.84 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $2,285.22 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $1,780.75 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $873.73 | 2019-2025 | Evenity, Repatha, Otezla |
| Allergan, INC. | $612.02 | 2019-2020 | |
| Pfizer INC. | $599.73 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $510.64 | 2019-2025 | Jardiance, Tradjenta, Ofev |
| Sanofi-Aventis U.S. LLC | $425.91 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $422.81 | 2019-2023 | Belsomra, Steglatro |
| Kowa Pharmaceuticals America, INC. | $413.84 | 2019-2024 | Seglentis, Livalo, Zoryve |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $377.90 | 2019-2025 | Trulance, Xifaxan |
| Antares Pharma, INC. | $364.85 | 2024-2025 | Xyosted |
| Axsome Therapeutics, INC. | $334.07 | 2022-2025 | Auvelity, Symbravo |
| Amarin Pharma, INC. | $331.49 | 2019-2022 |
Show all 73 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $325.72 | 2019-2025 | Trintellix |
| Astellas Pharma US INC | $288.32 | 2019-2023 | Veozah |
| Alkermes, INC. | $276.15 | 2023-2025 | Vivitrol, Vivitrol |
| Harmony Biosciences LLC | $229.76 | 2024-2025 | |
| Exact Sciences Corporation | $223.43 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Eisai INC. | $206.64 | 2020-2021 | |
| Glaxosmithkline, LLC. | $200.26 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Corcept Therapeutics | $199.27 | 2023 | Korlym |
| Abbott Laboratories | $192.85 | 2019-2025 | Freestyle Libre 3 |
| Corium, LLC | $173.64 | 2023-2025 | Azstarys |
| Sumitomo Pharma America, INC. | $159.08 | 2023-2025 | Gemtesa |
| Esperion Therapeutics, INC. | $145.78 | 2020-2022 | |
| Currax Pharmaceuticals LLC | $122.81 | 2021-2024 | Contrave, Nexletol, Nexlizet |
| Bayer Healthcare Pharmaceuticals INC. | $118.63 | 2022-2023 | |
| Actelion Pharmaceuticals US, INC. | $109.69 | 2024-2025 | Uptravi, Opsumit |
| Janssen Pharmaceuticals, INC | $107.66 | 2019-2021 | |
| Ethicon INC. | $106.26 | 2021 | |
| Noven Therapeutics, LLC | $97.36 | 2023-2024 | Xelstrym, Secuado |
| Sunovion Pharmaceuticals INC. | $90.54 | 2021-2022 | |
| Phathom Pharmaceuticals, INC. | $89.60 | 2024-2025 | Voquezna |
| Biohaven Pharmaceutical Holding Company LTD. | $88.03 | 2022 | |
| Supernus Pharmaceuticals, INC. | $86.80 | 2021-2023 | Qelbree, Xyosted |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $82.01 | 2022-2023 | |
| Nestle Healthcare Nutrition INC. | $81.81 | 2021-2022 | |
| Ironshore Pharmaceuticals INC. | $76.64 | 2019-2024 | |
| Verity Pharmaceuticals INC. | $71.38 | 2025 | Tlando |
| Neos Therapeutics, LP | $70.71 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $67.63 | 2019-2022 | |
| Vivus LLC | $65.12 | 2019-2023 | Pancreaze |
| Teva Pharmaceuticals USA, INC. | $63.58 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $55.17 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $55.02 | 2025 | Rexulti |
| Lucid Diagnostics INC. | $50.38 | 2022-2023 | |
| Radius Health, INC. | $48.94 | 2019-2024 | Tymlos |
| Collegium Pharmaceutical, INC. | $48.39 | 2025 | Jornay Pm |
| Dexcom, INC. | $46.41 | 2021-2024 | Dexcom G6 Transmitter |
| Tris Pharma INC | $45.90 | 2024 | Dyanavel Xr |
| Bausch Health US, LLC | $45.66 | 2023 | Wellbutrin, Aplenzin |
| Adlon Therapeutics L.P. | $45.11 | 2021 | |
| Endo Pharmaceuticals INC. | $43.83 | 2020-2022 | |
| Kaleo, INC. | $40.64 | 2020-2023 | Auvi-Q |
| Uswm, LLC | $40.09 | 2021 | |
| Idorsia Pharmaceuticals US INC | $39.79 | 2023 | Quviviq |
| Insulet Corporation | $29.75 | 2025 | Omnipod |
| Zyla Life Sciences, INC. | $26.22 | 2019 | |
| Cequr Corporation | $26.03 | 2024 | Cequr Simplicity |
| Xeris Pharmaceuticals, INC. | $20.19 | 2023 | Gvoke Hypopen |
| Renalytix Ai, INC. | $16.79 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Sun Pharmaceutical Industries INC. | $16.68 | 2020 | |
| Halozyme INC | $16.58 | 2023 | |
| Aimmune Therapeutics, INC. | $15.68 | 2024 | |
| Impel Pharmaceuticals INC. | $15.05 | 2023 | Trudhesa |
| Tolmar, INC. | $14.99 | 2024 | |
| Amneal Pharmaceuticals LLC | $14.00 | 2025 | Unithroid |
| Horizon Therapeutics Plc | $13.93 | 2019 | |
| Paratek Pharmaceuticals, INC. | $13.90 | 2024 | Nuzyra |
| Medtronic Vascular, INC. | $11.42 | 2019 | |
| Assertio Therapeutics, INC. | $11.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Leahy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.